Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
By Ryan Davis · March 30, 2026, 9:13 PM EDT
Drugmakers, industry groups, hospitals and scholars have urged the U.S. Supreme Court to uphold a decision letting a patent suit proceed over a generic drug using a so-called skinny label, saying...
To view the full article, register now.